Clinical and angiographic comparison of everolimus-eluting and paclitaxel-eluting stents in small coronary arteries: A post hoc analysis of the SPIRIT III randomized trial

American Heart Journal

Volumn 158, Issue 6, 2009, Pages 1005-1010

  Hermiller, James B ^a   Fergus, Todd ^a   Pierson, Wesley ^b   Su, Xiaolu ^b   Sood, Poornima ^b   Sudhir, Krishnankutty ^b   Stone, Gregg W ^c  

^a Care Group   (United States)

^b ABBOTT VASCULAR   (United States)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

'TAXUS'; ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; UNCLASSIFIED DRUG; XIENCE V;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD VESSEL DIAMETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HEART REINFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHESIS FAILURE; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; REVASCULARIZATION; SINGLE BLIND PROCEDURE; STENT THROMBOSIS;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PACLITAXEL; PROSPECTIVE STUDIES; SIROLIMUS;

EID: 70549091206     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2009.09.018     Document Type: Article

References (39)

1. Ellis S.G., Vandormael M.G., Cowley M.J., et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 82 (1990) 1193-1202 [see comment]
2. Hermiller Jr. J.B. Contemporary treatment of small-vessel disease. J Invasive Cardiol 16 (2004) 417-418 [comment]
3. Elezi S., Kastrati A., Neumann F.J., et al. Vessel size and long-term outcome after coronary stent placement. Circulation 98 (1998) 1875-1880
4. Akiyama T., Moussa I., Reimers B., et al. Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 32 (1998) 1610-1618
5. Hausleiter J., Kastrati A., Mehilli J., et al. Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol 40 (2002) 882-889
6. Hirshfeld Jr. J.W., Schwartz J.S., Jugo R., et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators. J Am Coll Cardiol 18 (1991) 647-656
7. Bourassa M.G., Lesperance J., Eastwood C., et al. Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 18 (1991) 368-376
8. Briguori C., Nishida T., Adamian M., et al. Coronary stenting versus balloon angioplasty in small coronary artery with complex lesions. Catheter Cardiovasc Interv 50 (2000) 390-397
9. Caputo R.P., Flately M., Ho K.K., et al. Safety and effectiveness of stent implantation without predilation for small coronary arteries. Catheter Cardiovasc Interv 59 (2003) 455-458
10. Huang P., Levin T., Kabour A., et al. Acute and late outcome after use of 2.5-mm intracoronary stents in small (<2.5 mm) coronary arteries. Catheter Cardiovasc Interv 49 (2000) 121-126 [see comment]
11. Moreno R., Fernandez C., Alfonso F., et al. Coronary stenting versus balloon angioplasty in small vessels: a meta-analysis from 11 randomized studies. J Am Coll Cardiol 43 (2004) 1964-1972 [see comment]
12. Foley D.P., Melkert R., and Serruys P.W. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 90 (1994) 1239-1251
13. Colombo A., and Chieffo A. Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease). Circulation 116 (2007) 1424-1432
14. Morice M.C. Stenting for small coronary vessels. J Invasive Cardiol 15 (2003) 377-379 [comment]
15. Stone G.W., Ellis S.G., Cox D.A., et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109 (2004) 1942-1947 [see comment]
16. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231 [see comment]
17. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323 [see comment]
18. Mauri L., Orav E.J., O'Malley A.J., et al. Relationship of late loss in lumen diameter to coronary restenosis in sirolimus-eluting stents. Circulation 111 (2005) 321-327
19. Pocock S.J., Lansky A.J., Mehran R., et al. Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials. J Am Coll Cardiol 51 (2008) 23-32 [see comment]
20. Mauri L., Orav E.J., and Kuntz R.E. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111 (2005) 3435-3442 [see comment]
21. Stone G.W., Midei M., Newman W., et al. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 299 (2008) 1903-1913 [see comment]
22. Kastrati A., Dibra A., Mehilli J., et al. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113 (2006) 2293-2300 [see comment]
23. Raisuke I., Yuji I., Akiyoshi M., et al. Predictors of restenosis after implantation of 2.5 mm stents in small coronary arteries. Circ J 68 (2004) 236-240
24. Moussa I., Moses J., Di Mario C., et al. Does the specific intravascular ultrasound criterion used to optimize stent expansion have an impact on the probability of stent restenosis?. Am J Cardiol 83 (1999) 1012-1017
25. Kastrati A., Schomig A., Dirschinger J., et al. randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators. Intracoronary stenting or angioplasty for restenosis reduction in small arteries. Circulation 102 (2000) 2593-2598
26. Park S.W., Lee C.W., Hong M.K., et al. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur Heart J 21 (2000) 1785-1789 [see comment]
27. Bass T.A. Stenting small vessels? Not a small issue. Catheter Cardiovasc Interv. 62 (2004) 430-431 [comment]
28. Schampaert E., Cohen E.A., Schluter M., et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115 [see comment]
29. Schofer J., Schluter M., Gershlick A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099 [see comment]
30. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223 [see comment]
31. Morice M.C., Colombo A., Meier B., et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial. JAMA 295 (2006) 895-904 [see comment]
32. Mauri L., Orav E.J., Candia S.C., et al. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 112 (2005) 2833-2839
33. Kereiakes D.J., Kuntz R.E., Mauri L., et al. Surrogates, substudies, and real clinical end points in trials of drug-eluting stents. J Am Coll Cardiol 45 (2005) 1206-1212 [see comment][comment]
34. Perin E.C. Choosing a drug-eluting stent: a comparison between CYPHER and TAXUS. Rev Cardiovasc Med 6 Suppl 1 (2005) S13-S21
35. Kereiakes D.J. Coronary small-vessel stenting in the era of drug elution. Rev Cardiovasc Med 5 Suppl 2 (2004) S34-S45
36. Marx S.O., and Marks A.R. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104 (2001) 852-855
37. Pache J., Kastrati A., Mehilli J., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Cardiol 41 (2003) 1283-1288 [see comment]
38. Kastrati A., Mehilli J., Dirschinger J., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 103 (2001) 2816-2821
39. Briguori C., Sarais C., Pagnotta P., et al. In-stent restenosis in small coronary arteries: impact of strut thickness. J Am Coll Cardiol 40 (2002) 403-409